Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5699355 | Clinical Oncology | 2010 | 6 Pages |
Abstract
This hypofractionated regimen is convenient for this patient population and produced comparable outcomes to longer fractionation schedules without an increase in late toxicity.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
N.A. Bayman, A.J. Sykes, S. Bonington, T. Blackburn, M. Patel, R. Swindell, N.J. Slevin,